Shares of Healthpeak Properties, Inc. (NYSE:DOC – Get Free Report) have been assigned a consensus rating of “Hold” from the eighteen analysts that are currently covering the firm, Marketbeat Ratings reports. Fourteen analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $21.7188.
A number of research firms have recently weighed in on DOC. Raymond James Financial started coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They issued a “market perform” rating for the company. Mizuho lifted their price target on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, July 6th. Barclays increased their price objective on Healthpeak Properties from $23.00 to $24.00 and gave the company an “equal weight” rating in a research note on Monday, August 31st. Cantor Fitzgerald raised their target price on shares of Healthpeak Properties from $20.00 to $23.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Finally, Scotiabank lifted their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Wednesday, May 27th.
View Our Latest Stock Report on Healthpeak Properties
Healthpeak Properties Price Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last issued its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The company had revenue of $771.58 million for the quarter, compared to analysts’ expectations of $725.64 million. During the same quarter last year, the company earned $0.46 EPS. The firm’s revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities research analysts expect that Healthpeak Properties will post 1.77 EPS for the current year.
Healthpeak Properties Dividend Announcement
The company also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be given a $0.1017 dividend. The ex-dividend date is Monday, September 14th. This represents a c) dividend on an annualized basis and a dividend yield of 5.9%. Healthpeak Properties’s payout ratio is presently 348.57%.
Hedge Funds Weigh In On Healthpeak Properties
Several hedge funds and other institutional investors have recently modified their holdings of the company. Advocate Investing Services LLC purchased a new position in Healthpeak Properties during the 4th quarter valued at about $26,000. Clearstead Trust LLC grew its position in shares of Healthpeak Properties by 66.7% in the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock worth $29,000 after buying an additional 543 shares during the last quarter. Elyxium Wealth LLC purchased a new position in shares of Healthpeak Properties during the fourth quarter valued at approximately $31,000. Clearstead Advisors LLC increased its stake in shares of Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after buying an additional 1,216 shares during the period. Finally, CYBER HORNET ETFs LLC bought a new position in shares of Healthpeak Properties during the second quarter valued at approximately $33,000. 93.57% of the stock is owned by institutional investors.
About Healthpeak Properties
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Articles
- Five stocks we like better than Healthpeak Properties
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
